Skip to content
Disclosery

Column Group LLC

Follow

13F filer, CIK 1833486, San Francisco, CA

Column Group LLC reported $65,721,031 across 5 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-008462

Period
2025-06-30
Reported value
$65.7M
Holdings
5
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000950123-25-008462, largest first. % of portfolio is the value over $65,721,031, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,540,777 shares; 2024Q4: 3,540,777 shares; 2025Q1: 3,540,777 shares; 2025Q2: 3,540,777 shares 3,540,777$35.9M54.68%0Timeline
Surrozen, Inc.Surrozen, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 810,088 shares; 2024Q4: 810,088 shares; 2025Q1: 1,499,773 shares; 2025Q2: 1,499,773 shares 1,499,773$13.4M20.4%0
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,680,621 shares; 2024Q4: 1,328,613 shares; 2025Q1: 1,328,613 shares; 2025Q2: 1,328,613 shares 1,328,613$10.6M16.17%0
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,400,290 shares; 2024Q4: 9,400,290 shares; 2025Q1: 9,400,290 shares; 2025Q2: 9,400,290 shares 9,400,290$5.74M8.74%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 46 shares; 2024Q4: 46 shares; 2025Q1: 46 shares; 2025Q2: 46 shares 46$1.69K<0.01%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-008462 base2025-08-15acceptance time not in the bulk data set